Eric Powers to Follow-Up Studies
This is a "connection" page, showing publications Eric Powers has written about Follow-Up Studies.
Connection Strength
0.207
-
Aortocoronary saphenous vein graft aneurysm causing high-gradient right ventricular outflow tract obstruction. Eur Heart J Cardiovasc Imaging. 2015 Jan; 16(1):117.
Score: 0.073
-
Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Cardiovasc Interv. 2006 Sep; 68(3):357-62.
Score: 0.042
-
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques. J Am Coll Cardiol. 2020 03 31; 75(12):1371-1382.
Score: 0.027
-
Outcome of patients with acute coronary syndromes and moderate coronary lesions undergoing deferral of revascularization based on fractional flow reserve assessment. Catheter Cardiovasc Interv. 2006 Oct; 68(4):544-8.
Score: 0.010
-
Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. Am J Cardiol. 2005 Nov 15; 96(10):1410-5.
Score: 0.010
-
Electromechanical mapping identifies improvement in function and retention of contractile reserve after revascularization in ischemic cardiomyopathy. Circulation. 2004 Oct 19; 110(16):2410-6.
Score: 0.009
-
One-year results of percutaneous myocardial revascularization for refractory angina pectoris. Am J Cardiol. 2003 Jun 01; 91(11):1342-6.
Score: 0.008
-
Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25; 105(25):2950-4.
Score: 0.008
-
Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention. Am J Cardiol. 1999 Sep 01; 84(5):589-92, A8.
Score: 0.006
-
Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 1995 Mar 01; 91(5):1403-9.
Score: 0.005
-
Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant. Cathet Cardiovasc Diagn. 1995 Jan; 34(1):88-95.
Score: 0.005
-
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15; 329(3):149-55.
Score: 0.004